New Leaf Venture Management III, L.L.C.'s Net Worth
$61.5 Million
Who is New Leaf Venture Management III, L.L.C.?
New Leaf Venture Management III, L.L.C. has an estimated net worth of $61.5 Million. This is based on reported shares across multiple companies, which include Deciphera Pharmaceuticals, Inc., ARVINAS INC., Edge Therapeutics, Inc., Harpoon Therapeutics, Inc., Iterum Therapeutics plc, and Aptinyx Inc..
SEC CIK
New Leaf Venture Management III, L.L.C.'s CIK is 0001625657
Past Insider Trading and Trends
2017 was New Leaf Venture Management III, L.L.C.'s most active year for acquiring shares with 6 total transactions. New Leaf Venture Management III, L.L.C.'s most active month to acquire stocks was the month of September. 2019 was New Leaf Venture Management III, L.L.C.'s most active year for disposing of shares, totalling 9 transactions. New Leaf Venture Management III, L.L.C.'s most active month to dispose stocks was the month of July. 2017 saw New Leaf Venture Management III, L.L.C. paying a total of $6,375,000.00 for 4,104,140 shares, this is the most they've acquired in one year. In 2019 New Leaf Venture Management III, L.L.C. cashed out on 2,842,834 shares for a total of $12,748,132.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Edge Therapeutics, Inc. (PDSB) Snapshot price: $5.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Iterum Therapeutics plc (ITRM) Snapshot price: $1.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Deciphera Pharmaceuticals, Inc. (DCPH) Snapshot price: $14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.53% | -350.00K |
$36.42 | -$12,748,132.08 | 3.75M |
Aug 15 - Aug 16
| |||
Form 4
|
∞
| 4.1M |
$17.00 |
—
| 4.1M |
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARVINAS INC. (ARVN) Snapshot price: $47.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.87M |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +488.96% | 1.54M |
—
|
—
| 1.86M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +34.68% | 235.29K |
$17.00 | $3,999,998.00 | 913.86K |
Jan 11
| |||
Form 4
| +117.19% | 2.92M |
$14.00 | $5,999,994.00 | 5.41M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |